Recognition of a new chemotherapeutic vesicant: trabectedin (ecteinascidin-743) extravasation with skin and soft tissue damage

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Journal of clinical oncology 2009-11, Vol.27 (33), p.e198-e200
Hauptverfasser:	Theman, Todd A, Hartzell, Tristan L, Sinha, Indranil, Polson, Kathleen, Morgan, Jeffrey, Demetri, George D, Orgill, Dennis P, George, Suzanne
Format:	Artikel
Sprache:	eng
Schlagworte:	Aged, 80 and over Antineoplastic Agents, Alkylating - administration & dosage Antineoplastic Agents, Alkylating - adverse effects Catheterization, Central Venous - adverse effects Device Removal Dioxoles - administration & dosage Dioxoles - adverse effects Drainage - methods Extravasation of Diagnostic and Therapeutic Materials Female Follow-Up Studies Humans Immunohistochemistry Infusions, Intravenous Irritants - adverse effects Leiomyosarcoma - drug therapy Leiomyosarcoma - pathology Necrosis - chemically induced Necrosis - pathology Necrosis - surgery Severity of Illness Index Skin Ulcer - chemically induced Skin Ulcer - pathology Skin Ulcer - surgery Soft Tissue Injuries - chemically induced Soft Tissue Injuries - physiopathology Soft Tissue Injuries - surgery Tetrahydroisoquinolines - administration & dosage Tetrahydroisoquinolines - adverse effects Treatment Outcome
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!